January 4, 2014 New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects
January 4, 2014 Progress in Tuberculosis Vaccine Development and Host-Directed Therapies–a State of the Art Review
April 2, 2014 Critical Path Institute Receives Grant to Accelerate Development of Tuberculosis Treatments
An Expanded Role for Patients in Clinical Trial Design – Podcast A discussion with Dr. Anne Rowzee of the Center for Drug Evaluation and Research, US FDA about patient input into the design of st
